Peptides HGH 10UI

hormone de croissance humaine 10UI est une hormone de croissance humaine présentée dans un flacon de 10 UI. Ce peptide est conçu pour être injecté, et peut aider les athlètes à améliorer leurs performances de plusieurs manières. Certains des avantages que les athlètes remarqueront sont une augmentation de la masse musculaire maigre., niveaux plus élevés de combustion des graisses, os renforcés, système immunitaire amélioré, augmentation des niveaux d’oxygène dans le sang, et une performance globale accrue lors de l'exercice tout en ayant également des propriétés anti-âge. Achetez HGH 10UI dans notre boutique en ligne. C'est à vendre à bon prix, et peut être expédié partout aux États-Unis par la poste.

Le produit contient de la somatropine synthétique, which is made up of 191-amino acids which mimic the same growth hormones that the body produces naturally. It is recommended that athletes take between 2IU-4IU daily to be injected subcutaneously, usually around the stomach area. Users will generally want to take this peptide for a minimum cycle of 8 weeks to achieve results, with many taking it in cycles of up to 4-6 months at a time. It is common to stack this with other steroids to get the best possible results in your cycle.

Even though HGH is not an anabolic steroid, it still may have some side effects when using this performance enhancer. Due to the way that HGH reacts with estrogen, gynecomastia is still a potential side effect for users. Joint pain, numbness in the hands and feet, hyperthyroidism, and diabetes are all possible side effects if the drug is not taken in proper doses.

The dosage of HGH must be adjusted for the individual patient. The weekly dose should be divided into daily subcutaneous injections (administered preferably in the evening). HGH may be given in the thigh, buttocks, or abdomen; the site of SC injections should be rotated daily to help prevent lipoatrophy. Pediatric GHD Patients: En général, a dose of 0.16 pour 0.24 mg/kg body weight/week is recommended. Adult GHD Patients: The recommended dosage at the start of therapy is not more than 0.04 mg/kg/week. The dose may be increased at 4- to 8-week intervals according to individual patient requirements to a maximum of 0.08 mg/kg/week, depending upon patient tolerance of treatment. Clinical response, Effets secondaires, and determination of age-adjusted serum IGF-I may be used as guidance in dose titration. This approach will tend to result in weight-adjusted doses that are larger for women compared with men and smaller for older and obese patients.